BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10972160)

  • 1. Polymers for use in controlled release systems: the effect of surfactants on their swelling properties.
    Vlachou M; Hani N; Efentakis M; Tarantili PA; Andreopoulos AG
    J Biomater Appl; 2000 Jul; 15(1):65-77. PubMed ID: 10972160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the characteristics of several polymer materials used in hydrophilic matrix tablets].
    Nie SF; Liu H; Liu YL; Pan WS
    Yao Xue Xue Bao; 2011 Mar; 46(3):338-43. PubMed ID: 21626791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swelling properties of various polymers used in controlled release systems.
    Vlachou M; Naseef H; Efentakis M; Tarantili PA; Andreopoulos AG
    J Biomater Appl; 2001 Oct; 16(2):125-38. PubMed ID: 11794722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of the pineal hormone melatonin from hydroxypropylmethylcellulose/sodium alginate matrices in aqueous media containing dioctyl sulfosuccinate.
    Vlachou M; Tsiakoulia A; Eikosipentaki A
    Curr Drug Discov Technol; 2007 Jun; 4(1):31-8. PubMed ID: 17630926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swelling properties of various polymers used in controlled release systems.
    Vlachou M; Naseef H; Efentakis M; Tarantili PA; Andreopoulos AG
    J Biomater Appl; 2001 Apr; 15(4):293-306. PubMed ID: 11336384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.
    Siahi-Shadbad MR; Asare-Addo K; Azizian K; Hassanzadeh D; Nokhodchi A
    AAPS PharmSciTech; 2011 Dec; 12(4):1176-82. PubMed ID: 21918920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modern polymers in matrix tablets technology].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(3):189-96. PubMed ID: 25739125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures.
    Moroni A; Drefko W; Thone G
    Drug Dev Ind Pharm; 2011 Feb; 37(2):216-24. PubMed ID: 20973612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST; Patel LD; Patel DM
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of surface properties of cellulose ethers and drug release from their matrix tablets.
    Sasa B; Odon P; Stane S; Julijana K
    Eur J Pharm Sci; 2006 Mar; 27(4):375-83. PubMed ID: 16413761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro/in vivo evaluation of the buccal bioadhesive properties of slow-release tablets containing miconazole nitrate.
    Mohammed FA; Khedr H
    Drug Dev Ind Pharm; 2003 Mar; 29(3):321-37. PubMed ID: 12741613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release.
    Efentakis M; Koligliati S; Vlachou M
    Int J Pharm; 2006 Mar; 311(1-2):147-56. PubMed ID: 16436321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
    Tadros MI
    Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs.
    Chavanpatil MD; Khdair A; Patil Y; Handa H; Mao G; Panyam J
    J Pharm Sci; 2007 Dec; 96(12):3379-89. PubMed ID: 17721942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):143-51. PubMed ID: 17240091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of polymeric films for buccal drug delivery.
    Skulason S; Asgeirsdottir MS; Magnusson JP; Kristmundsdottir T
    Pharmazie; 2009 Mar; 64(3):197-201. PubMed ID: 19348343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer film formulations for the preparation of enteric pharmaceutical capsules.
    Smith AM; Ingham A; Grover LM; Perrie Y
    J Pharm Pharmacol; 2010 Feb; 62(2):167-72. PubMed ID: 20487195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The macromolecular polymers for the preparation of hydrodynamically balanced systems--methods of evaluation.
    Dorozyński P; Jachowicz R; Kulinowski P; Kwieciński S; Szybiński K; Skórka T; Jasiński A
    Drug Dev Ind Pharm; 2004; 30(9):947-57. PubMed ID: 15554219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-drug interactions and wetting of solid dispersions.
    Dahlberg C; Millqvist-Fureby A; Schuleit M; Furó I
    Eur J Pharm Sci; 2010 Jan; 39(1-3):125-33. PubMed ID: 19932176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system.
    Yoo JW; Dharmala K; Lee CH
    Int J Pharm; 2006 Feb; 309(1-2):139-45. PubMed ID: 16376036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.